PQ 312
312. Deputy Pearse Doherty asked the Minister for Health when a decision will be made on the reimbursement of ocrelizumab for persons with multiple sclerosis; and if he will make a statement on the matter. [26067/19]
Introduced
25 June 2019
Last action
25 June 2019 · Medicinal Products Reimbursement
Status
written
Sponsors
Pearse Doherty
Subjects
Discovery layer
Source updated
25 June 2019
Summary
312. Deputy Pearse Doherty asked the Minister for Health when a decision will be made on the reimbursement of ocrelizumab for persons with multiple sclerosis; and if he will make a statement on the matter. [26067/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 June 2019
Medicinal Products Reimbursement
312. Deputy Pearse Doherty asked the Minister for Health when a decision will be made on the reimbursement of ocrelizumab for persons with multiple sclerosis; and if he will make a statement on the matter. [26067/19]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 25 June 2019
Sponsors
- Pearse Doherty · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-06-25/312/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-06-25/pq_312
- ireland · q-2019-06-25-pq_312 · source updated 25 June 2019